News and Announcements
Proteomics International Laboratories Appoints New Director
- Published October 19, 2015 11:59AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th October 2015, ASX Announcement
Life science company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce the appointment of Mr James Moses to the Company’s board as an executive director, effective form today.
Mr Moses has extensive experience in investment markets and the media developed in a career spanning 25 years, including a wealth of expertise in advising emerging small-cap public companies.
He will work closely with the Company’s leadership team to develop and implement appropriate strategies to maximise PILL’s awareness and penetration in investment markets and with external stakeholders.
To read the full announcement, please click here.